Metabolic Health & Biomarkers
Metabolic health and biomarker research — insulin resistance (HOMA-IR), HbA1c, ApoB, the TyG index, and visceral fat.
Insulin Resistance & HOMA-IR
Metabolic Health & Biomarkers
What is HOMA-IR and what does it tell you?
About this study
Type
Foundational method
The 1985 paper that introduced HOMA-IR — a way to estimate insulin resistance from one fasting blood draw rather than an invasive clamp test.
The finding
HOMA-IR estimates how resistant your body is to insulin using just two fasting numbers — blood glucose and insulin. A higher value means your pancreas is working harder to keep glucose in check, an early sign of metabolic trouble that often shows up years before blood sugar itself rises.
The answer
A fasting insulin-resistance score
Formula: (fasting glucose × fasting insulin) ÷ 405 (mg/dL units). No universal "bad" cutoff — thresholds vary by population.
Your HOMA-IR is a snapshot of insulin resistance from a routine fasting blood test — useful for spotting metabolic issues early. There is no single number that means "resistant" for everyone; healthy ranges differ by ethnicity and population (the next two cards show why). Watching your own value trend over time is more informative than one absolute reading. Interpret it with your doctor alongside your other markers.
Metabolic Health & Biomarkers
Is there one HOMA-IR cutoff that means insulin resistance?
About this study
People
3,071 adults
MetS cutoff
1.775 HOMA-IR
A national sample of Iranian adults. Researchers found the HOMA-IR value that best identified metabolic syndrome in this specific population.
The finding
In this Iranian population, the HOMA-IR level that best flagged metabolic syndrome was about 1.8 — noticeably lower than cutoffs found in European or Latin American groups. That's the whole point: there is no universal threshold, because insulin resistance shows up at different HOMA-IR values in different populations.
The answer
1.775 cutoff (this population)
Lower than European/Latin American cutoffs. For people with diabetes the cutoff rose to ~3.9–4.3.
Don't take a HOMA-IR cutoff you read online at face value — the "insulin resistant" threshold depends on the population it came from, and this Iranian value (~1.8) is lower than others. Use your own value as a personal trend and interpret it with your doctor against locally-relevant references, not a single internet number.
Metabolic Health & Biomarkers
Does the insulin-resistance cutoff change by population?
About this study
People
1,203 adults
IR cutoff
2.7 HOMA1-IR
A Brazilian study (BRAMS) that set an insulin-resistance cutoff from the values of its healthiest subgroup.
The finding
In this Brazilian population the HOMA-IR cutoff for insulin resistance was 2.7 — meaningfully higher than the ~1.8 from the Iranian study. Same tool, different threshold, purely because populations differ in body size, genetics, and diet.
The answer
2.7 cutoff (this population)
Higher than East Asian or Iranian cutoffs — same index, population-specific threshold.
Placed next to the Iranian study, this makes the lesson concrete: a HOMA-IR of 2.5 might be "resistant" in one population and "normal" in another. Track your own value over time and interpret it with a clinician using references relevant to you, rather than applying a foreign cutoff.
Metabolic Health & Biomarkers
Does cutting carbs help control blood sugar?
About this study
Co-signers
26 researchers
A position statement, not a trial — 26 researchers making the case for carbohydrate restriction as the first-line diet for type 2 diabetes. Several are well-known low-carb advocates.
The finding
The authors argue that cutting carbohydrates reliably lowers blood glucose — fast, without requiring weight loss, and often reducing diabetes medication. That's well-grounded for short-term glycemic control. But it's a position statement from advocates, not a neutral meta-analysis, and it frames carb restriction as superior to alternatives more strongly than direct comparisons support.
The answer
Yes — lowers blood glucose
Effect on glucose is immediate and doesn't require weight loss. Advocacy position statement, not a meta-analysis.
If you're managing high blood sugar or type 2 diabetes, reducing refined carbs is one of the most direct dietary levers — it lowers glucose quickly and can cut medication needs. Just treat "the best approach" claims with some caution: low-carb is effective, but so are other patterns (Mediterranean, overall calorie reduction). If you take glucose-lowering medication, change carbs in coordination with your doctor to avoid dangerous lows.
Metabolic Health & Biomarkers
How does exercise improve your insulin sensitivity?
About this study
Type
Narrative review
A review separating the immediate post-workout effect on insulin sensitivity from the longer-term adaptations of regular training.
The finding
Exercise improves insulin sensitivity two ways. A single session opens a window — muscle pulls in glucose for at least 16 hours afterward, partly without even needing insulin, because the muscle contraction itself does it. Training then locks in bigger, lasting gains by building more of the glucose-transport machinery (GLUT4) in muscle.
The answer
≥16 hours (per session)
One workout improves insulin sensitivity for at least 16 h; regular training makes the gains chronic.
Every workout gives you a same-day and next-day boost in how well your body handles blood sugar — which is why exercising most days keeps that window open continuously. Both cardio and lifting help; lifting adds muscle that acts as a glucose sink. The practical point is frequency: a session every day or two sustains the insulin-sensitivity benefit far better than one hard workout a week.
HbA1c as a Diet Quality Biomarker
Metabolic Health & Biomarkers
Does a lower-GI diet actually lower your HbA1c?
About this study
Effect on HbA1c
−0.42 SMD
A meta-analysis pooling trials in people with diabetes that compared low-glycemic-index diets against high-GI diets, tracking HbA1c and fructosamine.
The finding
Swapping high-glycemic-index foods (white bread, sugary drinks) for low-GI ones (whole grains, legumes) modestly improved long-term blood-sugar control in people with diabetes. HbA1c is the key marker here — it averages your blood sugar over months, so it reflects how you actually eat day to day, not just your last meal.
The answer
Yes — modestly
Low-GI vs high-GI: HbA1c standardized mean difference −0.42 in people with diabetes.
Choosing lower-GI carbs — beans, intact whole grains, fruit over juice — nudges your HbA1c down if you have diabetes or high blood sugar. It's a modest effect, best combined with overall calorie and refined-sugar control rather than relied on alone. Because HbA1c tracks months of eating, consistency matters more than any single meal.
Metabolic Health & Biomarkers
Does eating ultra-processed food raise your diabetes risk?
About this study
Studies pooled
12 cohorts
Per +10% UPF
+14 % risk
A pooled analysis of long-term observational studies tracking how much of people's diets came from ultra-processed foods and who later developed type 2 diabetes.
The finding
The more of someone's diet came from ultra-processed foods — packaged snacks, sugary drinks, processed meats — the higher their risk of developing type 2 diabetes, in a steady dose-response. Because this is observational, it can't prove UPF directly causes diabetes: heavy UPF eaters also tend to move less and eat fewer whole foods.
The answer
+14% diabetes risk per +10% UPF
Highest vs lowest UPF intake: ~48% higher risk. Observational — association, not proven cause.
Cutting back on ultra-processed foods is a reasonable, low-risk move for metabolic health — the association with diabetes is consistent and dose-dependent. But it's correlational, so don't read it as a precise "each snack costs you X." Focus on the overall shift toward minimally-processed foods rather than fearing any single item.
ApoB vs LDL-C: The Better Cardiovascular Risk Marker
Metabolic Health & Biomarkers
Is ApoB a better heart-risk marker than LDL cholesterol?
About this study
Studies pooled
12 studies
People
233,455 adults
A meta-analysis pooling a dozen large studies to see which cholesterol number best predicts heart attacks and strokes: standard LDL-C, non-HDL-C, or apolipoprotein B (ApoB).
The finding
ApoB — a count of the actual number of artery-clogging particles in your blood — predicted cardiovascular risk better than standard LDL cholesterol, which measures the cholesterol carried rather than the particle count. Two people with the same LDL-C can have very different particle numbers; ApoB captures the difference LDL-C misses.
The answer
ApoB wins
Predictive strength (relative risk ratio): ApoB 1.43 · non-HDL-C 1.34 · LDL-C 1.25.
If your LDL-C looks fine but you have high triglycerides, prediabetes, or metabolic syndrome, ask your doctor about an ApoB (or at least non-HDL-C) test — standard LDL-C can under-read your true risk in those cases. ApoB counts particles, and particle number is what drives artery disease. It doesn't replace LDL-C for everyone, but it resolves the cases where LDL-C is misleading.
Metabolic Health & Biomarkers
Does lowering cholesterol with vegetable oil save lives?
About this study
People
9,423 adults
Cholesterol
−13.8 %
Long-lost data from a 1968–73 randomized trial, recovered and re-analyzed decades later, comparing a saturated-fat diet against one high in omega-6 vegetable oil.
The finding
Swapping saturated fat for vegetable oil did lower cholesterol — but people didn't live longer, and those whose cholesterol dropped the most actually died at higher rates, especially older participants. It's a striking case where moving the cholesterol number the "right" way didn't move the outcome that matters.
The answer
No survival benefit
Cholesterol fell 13.8% but mortality didn't improve; more cholesterol-lowering tracked with ~22% higher death risk per 30 mg/dL drop.
The lesson isn't "cholesterol doesn't matter" — it's that a lower cholesterol number from one specific swap doesn't automatically mean lower risk. This is one older re-analysis with real limitations, not the final word, but it's part of why modern lipid care looks at particle count (ApoB) and overall diet pattern rather than just total or LDL cholesterol. Don't chase a single number in isolation.
Metabolic Health & Biomarkers
Does dietary cholesterol raise your heart risk?
About this study
Type
AHA advisory
An American Heart Association science advisory reviewing whether the cholesterol you eat (eggs, shellfish) meaningfully affects heart-disease risk.
The finding
For most people, cholesterol in food has only a small effect on blood cholesterol, and observational studies don't show a clear link between dietary cholesterol itself and heart disease. The catch is that many high-cholesterol foods are also high in saturated fat — and it's the overall dietary pattern, not cholesterol alone, that matters.
The answer
Small direct effect
No consistent link between dietary cholesterol alone and CVD; the advisory emphasizes overall diet pattern (Mediterranean/DASH).
You don't need to fear dietary cholesterol in isolation — an egg isn't the problem the old guidelines made it out to be. What matters is the whole pattern: emphasize vegetables, whole grains, legumes, fish, and nuts, and watch the saturated fat that often rides along with high-cholesterol foods. Aim for a healthy pattern rather than counting milligrams of cholesterol.
Visceral Adiposity & Metabolic Syndrome
Metabolic Health & Biomarkers
What is metabolic syndrome and why does it matter?
About this study
Criteria
3 of 5 to diagnose
The harmonized international definition agreed by the IDF, AHA, WHO, and others. Metabolic syndrome is a cluster of risk factors that tend to travel together.
The finding
Metabolic syndrome is diagnosed when you have any three of five markers: a large waist, high triglycerides, low HDL, elevated blood pressure, and high fasting glucose. Having the cluster roughly doubles cardiovascular risk and multiplies type-2-diabetes risk several-fold — and waist size (visceral fat) is the linchpin, because belly fat drives inflammation and insulin resistance.
The answer
3 of 5 criteria = diagnosis
Waist (population-specific) · triglycerides ≥1.7 mmol/L · HDL <1.0/1.3 (M/F) · BP ≥130/85 · glucose ≥5.6 mmol/L. ~2× CVD, ~5× T2D risk.
Check yourself against the five: waist circumference, triglycerides, HDL, blood pressure, fasting glucose. Three or more flags metabolic syndrome — a strong signal to act, since it sharply raises diabetes and heart risk. The good news: the same moves — losing visceral fat, exercising, cutting refined carbs — improve several criteria at once. Waist size is the one to watch first.